Cargando…
Targeted Approaches in Metastatic Castration-Resistant Prostate Cancer: Which Data?
SIMPLE SUMMARY: Castration-resistant prostate cancer (CRPC) remains an incurable disease, but some promising innovative treatment options are under investigation. Recent developments in precision medicine have enabled the identification of new predictive biomarkers and potential targeted agents. The...
Autores principales: | Mosillo, Claudia, Calandrella, Maria Letizia, Caserta, Claudia, Macrini, Serena, Guida, Annalisa, Sirgiovanni, Grazia, Bracarda, Sergio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454420/ https://www.ncbi.nlm.nih.gov/pubmed/36077726 http://dx.doi.org/10.3390/cancers14174189 |
Ejemplares similares
-
Nectin-4 and DNA mismatch repair proteins expression in upper urinary tract urothelial carcinoma (UTUC) as a model for tumor targeting approaches: an ImGO pilot study
por: Calandrella, Maria Letizia, et al.
Publicado: (2022) -
Looking for a Simplified Diagnostic Model to Identify Potentially Lethal Cases of Prostate Cancer at Initial Diagnosis: An ImGO Pilot Study
por: Macrini, Serena, et al.
Publicado: (2022) -
Monitoring Patients with Metastatic Hormone-Sensitive and Metastatic Castration-Resistant Prostate Cancer: A Multidisciplinary Consensus Document
por: Lapini, Alberto, et al.
Publicado: (2019) -
Radiotherapy in metastatic castration resistant prostate cancer patients with oligo-progression during abiraterone-enzalutamide treatment: a mono-institutional experience
por: Valeriani, Maurizio, et al.
Publicado: (2019) -
Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches
por: Awang, Zool Hilmi, et al.
Publicado: (2018)